Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-11-021749
Filing Date
2011-03-03
Accepted
2011-03-03 17:05:43
Documents
12
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y90065e10vk.htm 10-K 1258943
2 EX-21.A y90065exv21wa.htm EX-21.A 1682
3 EX-23.A y90065exv23wa.htm EX-23.A 3426
4 EX-31.A y90065exv31wa.htm EX-31.A 8814
5 EX-31.B y90065exv31wb.htm EX-31.B 8914
6 EX-32.A y90065exv32wa.htm EX-32.A 3898
7 EX-32.B y90065exv32wb.htm EX-32.B 3919
8 EX-99.1 y90065exv99w1.htm EX-99.1 122793
10 GRAPHIC y90065y9006501.gif GRAPHIC 11160
11 GRAPHIC y90065y9006502.gif GRAPHIC 3527
12 GRAPHIC y90065y9006503.gif GRAPHIC 1609
13 GRAPHIC y90065y9006504.gif GRAPHIC 9276
  Complete submission text file 0000950123-11-021749.txt   1449293
Mailing Address 25 UPTON DRIVE WILMINGTON MA 01887
Business Address 25 UPTON DRIVE WILMINGTON MA 01887 9786577500
DUSA PHARMACEUTICALS INC (Filer) CIK: 0000879993 (see all company filings)

EIN.: 223103129 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31533 | Film No.: 11661049
SIC: 2834 Pharmaceutical Preparations